Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study
Authors
Keywords
FDG PET/CT, Hepatocellular carcinoma, Standardized uptake value, Prognosis, Multicenter trial
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 43, Issue 9, Pages 1638-1645
Publisher
Springer Nature
Online
2016-03-02
DOI
10.1007/s00259-016-3348-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis
- (2015) Jeong Won Lee et al. ANNALS OF NUCLEAR MEDICINE
- Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE
- (2015) H.-J. Song et al. CLINICAL RADIOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation
- (2014) Jae Seon Eo WORLD JOURNAL OF GASTROENTEROLOGY
- The Prognostic Value of 18F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)
- (2014) Wenhui Ma et al. Theranostics
- A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function
- (2013) S.G. Ahn et al. EJSO
- 18F-Fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma
- (2013) Myeong Jun Song et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of 18F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma
- (2013) Vineet Pant et al. NUCLEAR MEDICINE COMMUNICATIONS
- Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience
- (2013) Sung Keun Park et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Preoperative FDG-PET Predicts Recurrence Patterns in Hepatocellular Carcinoma
- (2011) Koji Kitamura et al. ANNALS OF SURGICAL ONCOLOGY
- Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
- (2011) Irene Bargellini et al. EUROPEAN JOURNAL OF RADIOLOGY
- The Role of Preoperative [18F]Fluorodeoxyglucose Positron Emission Tomography in Predicting Early Recurrence After Curative Resection of Hepatocellular Carcinomas
- (2011) Sung Gwe Ahn et al. JOURNAL OF GASTROINTESTINAL SURGERY
- 18F-FDG-Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant Patients
- (2009) A. Kornberg et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prediction of Tumor Recurrence by 18F-FDG PET in Liver Transplantation for Hepatocellular Carcinoma
- (2009) J. W. Lee et al. JOURNAL OF NUCLEAR MEDICINE
- A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma
- (2008) J.-W. Park et al. JOURNAL OF NUCLEAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started